Page 59 - Sciences News Today

Boomers and consumers spend; companies stash cash; housing finds buyers and inflation eases.

By Adriano Marchese NKGen Biotech said Wednesday it has received regulatory clearance to begin trials for its cell therapy to treat patients with moderate...

News publisher says AI tools use its content without permission; tech companies have said training AI with web content is ‘fair use’

The Times alleges that Microsoft’s Copilot and OpenAI’s ChatGPT have unlawfully used the publication’s work to create artificial intelligence products that...

The biotech sector is rallying once again, but picking the winners is anything but easy

Biotech stocks have gotten a boost from the Fed and from M&A.

The OpenAI CEO lost the confidence of top leaders in the three organizations he has directed, yet each time he’s rebounded to greater heights

Cash deal would help Bristol establish a beachhead in neuroscience drugs, including a schizophrenia treatment up for approval

A more favorable interest-rate outlook, an uptick in deals, and innovations in key areas like cancer and immunology are setting up biotech for a brighter...

After sneaking his AI-written water bill into law, Ramiro Rosário says government press-release writers could go, too